However, in contrast to HL and DLBCL, these changes from baseline did not reach statistical significance and levels of nDNA at day 22 remained elevated compared with healthy controls (geometric means baseline 1.87; day 22 0.95; controls 0.29; K–W P <0.005).
← all excerpts
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma.
1
0.0050
0.0050